Pfizer Inc Capital Reinvestment Ratio
Pfizer Inc capital reinvestment ratio. Pfizer Inc (PFIZ34) has a Capital Reinvestment Ratio of 0.64x as of June 2026, meaning it reinvests 1% of its operating cash flow (R$835.00 Million) in capital expenditures (R$533.00 Million). Check Pfizer Inc (PFIZ34) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pfizer Inc (2014–2025)
Capital reinvestment ratio of Pfizer Inc from 2014 to 2025. This chart tracks Pfizer Inc's Capital Reinvestment Ratio across 12 annual periods. Also explore Pfizer Inc annual equity growth to track the company's year-over-year net asset growth rate.
Pfizer Inc Capital Reinvestment Ratio by Year (2014–2025)
Pfizer Inc capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see PFIZ34 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | R$11.71 Billion | R$2.63 Billion | ▼ -1.6% |
| 2024 | 0.23x | R$12.74 Billion | R$2.91 Billion | ▼ -28.9% |
| 2023 | 0.32x | R$12.04 Billion | R$3.86 Billion | ▲ +190.2% |
| 2022 | 0.11x | R$29.27 Billion | R$3.24 Billion | ▲ +32.9% |
| 2021 | 0.08x | R$32.58 Billion | R$2.71 Billion | ▼ -57.1% |
| 2020 | 0.19x | R$14.40 Billion | R$2.79 Billion | ▼ -6.0% |
| 2019 | 0.21x | R$12.59 Billion | R$2.59 Billion | ▲ +48.5% |
| 2018 | 0.14x | R$15.83 Billion | R$2.20 Billion | ▲ +5.2% |
| 2017 | 0.13x | R$16.80 Billion | R$2.22 Billion | ▲ +6.9% |
| 2016 | 0.12x | R$16.19 Billion | R$2.00 Billion | ▲ +29.8% |
| 2015 | 0.10x | R$14.69 Billion | R$1.40 Billion | ▲ +35.5% |
| 2014 | 0.07x | R$17.08 Billion | R$1.20 Billion | — |